NeutriSci International Stock (OTC: NRXCF)

Latest News for NeutriSci International Stock (OTC:NRXCF)

NeutriSci International Inc is a Canada-based company engaged in the market development of nutraceutical products. The company's revenue consists of sales of the Neueenergy product line.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAME

AERI

AMCX

AMHPF

AQMS

ASIX

AXAS

AXIM

BWVI

CBDD

CCORF

CHNC

CPIX

CRZO

CTRA

DIRV

DLPH

DRWN

EBIX

ETRN

EXTN

FNGR

GNPX

GNUS

GRSO

GVSI

HCMC

HMLN

HVBTF

IDRA

IDXG

IIVI

INCAF

INQD

IPIX

JWCAF

KATFF

KGET

KOSS

LGORF

LTBR

MACK

MBII

MGNX

MODERN CINEMA GROUP INC by Modern Cinema Group, Inc.

MOCI

MRRMF

NDRA

NECA

NGHC

NHTC

NOHO

NRGMF

NEUTRISCI INTL INC ORD by Neutrisci Intl Inc

NRXCF

NSPDF

NTSFF

NVAX

NVIV

OCANF

OGDCF

PMGYF

PNNT

PRTY

QILFF

RAIL

RBBN

RLBD

RMBL

RNWK

ROKK

ROYT

SDRL

SPLIF

SPUP

SRAX

Stocks That Hit 52-Week Lows On Thursday

NeutriSci International Inc

<p>The crypto community is buzzing with excitement as the highly anticipated <a href="https://www.benzinga.com/topic/bitcoin-halving">Bitcoin Halving</a> event is set to commence in just a few hours.</p>
<p><strong>What Happened:</strong> <strong>Bitwise</strong> CIO Matt <strong>Hougan</strong> in his Friday <a href="https://www.cnbc.com/video/2024/04/19/bitcoin-prices-will-rally-substantially-after-this-weeks-halving-says-bitwise-cio-matt-hougan.html">interview</a> with CNBC stated that <strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is experiencing a demand shock from the launch of spot Bitcoin ETFs and a supply shock from the Halving. Both events occurring at the same time have created an exciting setup for the crypto industry.</p>
<p>Crypto trader <strong>Stockmoney Lizards</strong> recently <a href="https://twitter.com/StockmoneyL/status/1781218191600955450">highlighted</a> Bitcoin&#8217;s pump off the horizontal support zone, indicating a local bottom. However, the ascending trendline continues to serve as a significant resistance point, suggesting that the correction phase is still in progress.</p>
<p>Renowned market analyst <strong>The Flow Horse</strong> shared a lighthearted <a href="https://twitter.com/TheFlowHorse/status/1781057301727592729">tweet</a> depicting a series of bounces and drops, indicating a volatile period ahead for investors. </p>
<p>He predicts a 20% drop after the first bounce, which will create panic selling, followed by a marginal bounce back as investors regain confidence. The Flow Horse expects this pattern of drops and bounces to repeat three to four times until emotional fatigue sets in, leading to a market slowdown until Labor Day.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/money/is-ethereum-a-good-investment"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure></p>
<p><em>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38321951/what-happens-after-the-bitcoin-halving">What Happens After The Bitcoin Halving?</a></em></p>
<p><strong>Why It Matters:</strong> The Bitcoin Halving, which occurs approximately every four years, reduces the number of new bitcoins created and earned by miners by half. This event is often associated with price volatility in the cryptocurrency market.</p>
<p>Crypto trader <strong>PlanB</strong> <a href="https://twitter.com/100trillionUSD/status/1781260966295924813">estimates</a> a 4x surge in Bitcoin&#8217;s price within the next 6 to 18 months following the Halving, as &#8220;the rest of the market rushes to get a piece of the pie.&#8221;</p>
<p>While experts forecast volatile price movements in Bitcoin after the Halving, investors are advised to approach the market with caution during this period, keeping in mind the potential for rapid changes in market conditions.</p>
<p><strong>What's Next</strong>: The influence of <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga's upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38277523/bitcoin-halving-jitters-why-10x-research-urges-caution">Bitcoin Halving Jitters: Why 10x Research Urges Caution</a></em></p>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Happy Bitcoin Halving Day: What Experts Predict Happens Next

<p>Value Line, Inc. (NASDAQ: <strong>VALU</strong>) announced today that its Board of Directors declared on April 19, 2024 a quarterly cash dividend of $0.30 per common share, payable on May 10, 2024, to stockholders of record on April 29, 2024. The 2024 increase of eight cents per year when annualized represents the tenth consecutive year of increases for the 93-year-old investment research icon. Based on a full year at the new rate, the new dividend level will reach $1.20 per share. The Company has 9,422,983 shares of common stock outstanding as of April 19, 2024.</p>


Dividends

VALU

Value Line Announces Increase Quarterly Cash Dividend From $0.28 To $0.30 Per Common Share

WIIM

CAMT

KLAC

MCHP

MPWR

QCOM

Shares of semiconductor and chip stocks are trading lower. The sector has been under pressure this week following earnings from ASML and TSMC. Stocks have been mixed Friday amid overall market uncertainty on Iran-Israel tensions.

<p>Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain &#8230; LSD," and he made sure his interview did not disappoint.</p>
<p><strong>Mind Medicine Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by 2025.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/money/zette"><strong>Anyone can invest in this Harvard-founded AI startup</strong></a></strong><strong> solving paywalls and growing 5x yearly by partnering with Forbes, Daily News and more.</strong></li>
<li><strong></strong><strong>Invest alongside execs from Uber, Facebook and Apple in this<a href="https://www.benzinga.com/money/aura"><strong> </strong><strong>wellness app Transforming a $5.6 TRILLION dollar industry</strong></a>.</strong></li>
</ul>
<p>While the conditions they're seeking to treat are not new, MindMed's plan to treat patients with LSD and MDMA-derived therapies could be described as unconventional.</p>
<p>But its story has gained investors' attention. MindMed shares have had an impressive run this year, with its stock up over 167% year to date.</p>
<p>One reason for the stock's recent jump was the Food and Drug Administration's (FDA) decision to grant breakthrough designation for MindMed's LSD-based treatment for generalized anxiety disorder.</p>
<p><a href="https://www.benzinga.com/topic/mindmed">MindMed</a> Chief Medical Officer Dr. Daniel Karlin described the achievement, saying, "A breakthrough designation is a recognition that a drug has demonstrated evidence of clinical efficacy in meeting an unmet medical need" and called it "an offer from the agency to engage more closely in drug development."</p>
<p><strong>Trending: Invest like a millionaire. Exclusive opportunity to<a href="https://www.benzinga.com/money/epic-games"><strong> </strong><strong>invest in Epic Games $17 billion gaming empire.</strong></a></strong></p>
<p>Following the interview, Cramer suggested that scientific advances in psychedelics-based therapy are taking a backseat to political agendas, posting on X that "<a href="https://t.co/OfcgQY7TtX">Mindmed.com</a> intrigued me because it is pretty clear that the LSD-derived antidepressants were blocked politically and criminalized after good tests showing they worked!!!"</p>
<p>MindMed reported results from its phase IIB trial of its MM-120 drug, an LSD-derived therapy, which showed a 78% clinical response against anxiety versus just 31% for a placebo.</p>
<p>Only "transient mild-to-moderate" adverse effects were reported, with none of the study's participants in even the highest trial doses stopping the trial because of side effects.</p>
<p>"These promising findings represent a major step forward in our goal to bring a paradigm-shifting treatment to the millions of patients who are profoundly impacted by GAD [generalized anxiety disorder]," MindMed CEO Robert Barrow said.&nbsp;</p>
<p>MindMed's shares still have a long way to go to get back to its 2021 peak, with the stock down nearly 84% since then.</p>
<p>The stocks of other companies developing psychedelic-derived therapies, such as <strong>ATAI Life Sciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) and <strong>Compass Pathways</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>), also remain well off their peaks.</p>
<p><strong>Keep Reading <a href="https://www.benzinga.com/alternative-investments/startups"><strong>About Startups</strong></a>:</strong></p>
<ul>
<li><strong></strong><strong>This startup coined &#8220;eBay for gamers&#8221; with a breathtaking track record has opened up<a href="https://www.benzinga.com/money/gameflip-2"><strong> a window to invest in its future growth</strong></a>.</strong></li>
<li><strong></strong><strong>Join the elite. Invest in Epic Games and<a href="https://www.benzinga.com/money/epic-games"><strong> </strong><strong>own a piece of the $17 billion Fortnite empire</strong></a>.</strong></li>
</ul>


ATAI

CMPS

MNMD

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'

ALAB

Astera Labs shares are trading lower. The stock may be experiencing continued post-IPO volatility.

<p>Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 25% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $307,804, and 4 were calls, valued at $200,253.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $43.0 to $55.0 for Bristol-Myers Squibb over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $43.0 to $55.0 in the last 30 days. </p>
<h3>Bristol-Myers Squibb 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713554179_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.5</td>
<td>$55.00</td>
<td>$107.2K</td>
<td>667</td>
<td>143</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.6</td>
<td>$3.4</td>
<td>$3.52</td>
<td>$45.00</td>
<td>$105.6K</td>
<td>1.2K</td>
<td>0</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$7.3</td>
<td>$7.15</td>
<td>$7.25</td>
<td>$43.00</td>
<td>$90.6K</td>
<td>60</td>
<td>126</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.5</td>
<td>$55.00</td>
<td>$65.2K</td>
<td>667</td>
<td>230</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$0.99</td>
<td>$0.98</td>
<td>$0.98</td>
<td>$50.00</td>
<td>$56.7K</td>
<td>7.6K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Bristol-Myers Squibb</h3>
<p>Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.</p>
<p>Following our analysis of the options activities associated with Bristol-Myers Squibb, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Bristol-Myers Squibb</h3>
<ul>
<li>Currently trading with a volume of 5,739,707, the BMY's price is up by 1.38%, now at $48.97. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 6 days.</li>
</ul>
<h3>What The Experts Say On Bristol-Myers Squibb</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $52.0.</p>
<ul>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Bristol-Myers Squibb, targeting a price of $52. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bristol-Myers Squibb with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

A Closer Look at Bristol-Myers Squibb's Options Market Dynamics

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>SolarEdge Technologies</strong>.</p>
<p>Looking at options history for SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) we detected 17 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 5% of the investors opened trades with bullish expectations and 94% with bearish.</p>
<p>From the overall spotted trades, 13 are puts, for a total amount of $901,434 and 4, calls, for a total amount of $112,260.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $500.0 for SolarEdge Technologies over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of SolarEdge Technologies stands at 437.87, with a total volume reaching 745.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in SolarEdge Technologies, situated within the strike price corridor from $40.0 to $500.0, throughout the last 30 days.</p>
<h3>SolarEdge Technologies 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713554174_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$74.0</td>
<td>$74.0</td>
<td>$74.0</td>
<td>$130.00</td>
<td>$436.6K</td>
<td style="text-align: right;">823</td>
<td style="text-align: right;">59</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$4.85</td>
<td>$4.7</td>
<td>$4.8</td>
<td>$50.00</td>
<td>$69.1K</td>
<td style="text-align: right;">929</td>
<td style="text-align: right;">181</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$14.2</td>
<td>$14.0</td>
<td>$14.15</td>
<td>$65.00</td>
<td>$49.5K</td>
<td style="text-align: right;">259</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$443.2</td>
<td>$439.05</td>
<td>$443.2</td>
<td>$500.00</td>
<td>$44.3K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$446.15</td>
<td>$439.05</td>
<td>$443.11</td>
<td>$500.00</td>
<td>$44.3K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
</tr>
</tbody>
</table>
</p>
<h3>About SolarEdge Technologies</h3>
<p>SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.</p>
<p>Having examined the options trading patterns of SolarEdge Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of SolarEdge Technologies</h3>
<ul>
<li>Currently trading with a volume of 1,069,677, the SEDG's price is down by -3.09%, now at $55.62. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 19 days.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SolarEdge Technologies with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


SEDG

Market Whales and Their Recent Bets on SEDG Options

<p>Deep-pocketed investors have adopted a bearish approach towards PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PYPL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for PayPal Holdings. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 23% leaning bullish and 76% bearish. Among these notable options, 13 are puts, totaling $1,016,091, and 17 are calls, amounting to $1,537,611.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $85.0 for PayPal Holdings over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for PayPal Holdings options trades today is 4257.54 with a total volume of 14,273.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for PayPal Holdings's big money trades within a strike price range of $40.0 to $85.0 over the last 30 days.</p>
<h3>PayPal Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713554169_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$1.7</td>
<td>$1.69</td>
<td>$1.7</td>
<td>$67.50</td>
<td>$342.0K</td>
<td>4.1K</td>
<td>2.0K</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.75</td>
<td>$62.50</td>
<td>$332.5K</td>
<td>4.2K</td>
<td>58</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$3.75</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$62.50</td>
<td>$237.5K</td>
<td>6.3K</td>
<td>802</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$2.45</td>
<td>$2.43</td>
<td>$2.45</td>
<td>$65.00</td>
<td>$196.0K</td>
<td>11.4K</td>
<td>845</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$9.85</td>
<td>$9.5</td>
<td>$9.75</td>
<td>$52.50</td>
<td>$185.2K</td>
<td>870</td>
<td>0</td>
</tr>
</tbody>
</table>
</p>
<h3>About PayPal Holdings</h3>
<p>PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 426 million active accounts at the end of 2023. The company also owns Venmo, a person-to-person payment platform.</p>
<p>Following our analysis of the options activities associated with PayPal Holdings, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is PayPal Holdings Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 8,245,581, with PYPL's price down by -0.55%, positioned at $61.76.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 11 days.</li>
</ul>
<h3>Expert Opinions on PayPal Holdings</h3>
<p>4 market experts have recently issued ratings for this stock, with a consensus target price of $68.0.</p>
<ul>
<li>Maintaining their stance, an analyst from JMP Securities continues to hold a Market Outperform rating for PayPal Holdings, targeting a price of $70. </li>
<li>Consistent in their evaluation, an analyst from Evercore ISI Group keeps a In-Line rating on PayPal Holdings with a target price of $60. </li>
<li>In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $74. </li>
<li>An analyst from Bernstein has decided to maintain their Market Perform rating on PayPal Holdings, which currently sits at a price target of $68. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for PayPal Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


PYPL

Check Out What Whales Are Doing With PYPL

Medical Properties Trust shares are trading lower. The stock spiked earlier in the week on a deal to sell its majority interest in Utah Hospitals.

TSLA

PepsiCo Executive Says Put 36 Tesla Semis On The Road To Haul Chips And Soda, Had Planned To Have 100 In Use By 2023; Spokesperson Says Tesla Semi Plans Can Shift When Technology And The Need To Establish Infrastructure Is Involved

<p>Stifel  analyst Ian Gillies   maintains Stelco Holdings (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STLC#TSX">STLC</a>) with a Buy and lowers the price target from C$52 to C$49.</p>


Price Target

Analyst Ratings

TSX:STLC

Stifel Maintains Buy on Stelco Holdings, Lowers Price Target to C$49

<p><strong>Immutable's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>) price has increased 4.8% over the past 24 hours to <strong>$2.07</strong>. Over the past week, IMX has experienced an uptick of over 1.0%, moving from $2.08 to its current price.  As it stands right now, <strong>the coin's all-time high is $9.52</strong>. </p>
<p>The chart below compares the price movement and volatility for Immutable over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553426_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has fallen 14.0% over the past week which is opposite, directionally, with the overall circulating supply of the coin, which has increased 3.56%. This brings the circulating supply to 1.46 billion, which makes up an estimated 72.84% of its max supply of 2.00 billion. According to our data, the current market cap ranking for IMX is #41 at $3.01 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553426_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$IMX

Cryptocurrency Immutable's Price Increased More Than 4% Within 24 hours

<p><strong>Nvidia Corporation </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares are trading lower Friday. Earnings from <strong>ASML Holdings N.V.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) and <strong>Taiwan Semiconductor Manufacturing Company Ltd.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) have put pressure on <a href="https://www.benzinga.com/markets/equities/24/04/38328610/tsmc-cautions-red-hot-chip-industry-growth-could-cool-amid-declining-automotive-chip-demand">the semiconductor sector</a>.&nbsp;</p>
<p><strong>The Details:</strong></p>
<p>ASML reported worse-than-expected earnings earlier in the week, followed by TSMC's<a href="https://www.benzinga.com/news/earnings/24/04/38320056/whats-going-on-with-apple-supplier-taiwan-semi-stock-on-thursday"> reduced outlook</a> for the chip market, overshadowing the company's Q1 results.</p>
<p>Shares of semiconductor companies are falling as investors consider the latest data and the possibility of reduced revenues as the first-quarter earnings season gets underway.</p>
<p>ASML and TSMC shares are down approximately 10% over the past five days.&nbsp; Nvidia shares have lost more than 11% this week and are trading below the $800 mark at $784.06 at the time of publication.&nbsp;</p>
<p><strong>Super Micro Computer, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are down more than 21% Friday after the company announced its third-quarter earnings release date and did not provide preliminary estimates as it has in the past. Investors are concerned that this foreshadows less-than-stellar financial results from the company ahead.&nbsp;</p>
<p><em>Related News: </em><a href="https://www.benzinga.com/news/24/04/38324715/whats-going-on-with-google-parent-alphabet-stock-ahead-of-earnings"><em>What&#8217;s Going On With Google Parent Alphabet Stock Ahead Of Earnings?</em></a></p>
<h2 class="wp-block-heading"><strong>Should I Sell My NVDA Stock?</strong></h2>
<p>Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.</p>
<p>Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.</p>
<p>Shares of Nvidia have gained 186.87% year to date. This compares to the average annual return of 76.76%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. </p>
<p>Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. NVIDIA stock currently has an RSI of 38.47, indicating neutral conditions.</p>
<p>For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> </p>
<p><strong>NVDA Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Nvidia shares are down 8.65% at $774.81 at the time of publication Friday.</p>
<p><em>Image: Shutterstock</em></p>


ASML

NVDA

SMCI

What's Going On With Nvidia's Stock?

<p>Over the past 24 hours, <strong>dogwifhat's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) price has risen 17.82% to <strong>$3.02</strong>. This continues its positive trend over the past week where it has experienced a 13.0% gain, moving from $2.69 to its current price. As it stands right now, <strong>the coin's all-time high is $4.83</strong>. </p>
<p>The chart below compares the price movement and volatility for dogwifhat over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553356_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has risen 51.0% over the past week diverging from the circulating supply of the coin, which has decreased 0.16%. This brings the circulating supply to 998.93 million, which makes up an estimated 100.0% of its max supply of 998.93 million. According to our data, the current market cap ranking for WIF is #39 at $3.02 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553356_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$WIF

Cryptocurrency dogwifhat's Price Increased More Than 17% Within 24 hours

<p><strong>Vision Sensing Acquisition Corp. (NASDAQ:</strong><a href="https://www.benzinga.com/stock/VSACU#NASDAQ"><strong>VSACU</strong></a><strong>, VSAC, VSACW)))</strong> (the "<strong>Company</strong>" or "<strong>VSAC</strong>"), a special purpose acquisition company, issues an update regarding the previously announced staff determination letter (the "Letter") received on&nbsp;January 17, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("<strong>Nasdaq</strong>") notifying the Company of the determination from the Nasdaq Staff (the "<strong>Staff</strong>").<br /><br />&nbsp;</p>
<p>As stated, the Letter was issued to the Company as the Company is not in compliance with the market value requirement as set forth Listing Rule 5450(b)(2)(A) (the "<strong>Market Value Requirement</strong>"), and the minimum 400 total holders requirement, as is required by Listing Rule 5450(a)(2) (the "<strong>Total Holders Requirement</strong>"). The Letter also states that the Company has not yet filed its Form 10-Q for the period ended September 30, 2023 (the "<strong>Filing</strong>") and is therefore not in compliance with Listing Rule 5250(c)(1).</p>
<p>On January 23, 2024, the Company submitted an appeal to the appeal Staff's determination to a Hearings Panel (the "<strong>Panel</strong>"), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. This submission included a detailed Compliance Plan, to present to the Panel, to regain compliance with the Listing Rules and also requested a stay of the suspension of the Company's securities. The Hearing request has stayed the suspension of the Company's securities and the filing of the Form 25-NSE with the Securities and Exchange Commission (the "SEC"). On January 24, 2024, the Company was notified, by the Nasdaq Hearings Advisor, that the hearing is scheduled to be held on April 4, 2024. The Company's securities are still eligible to trade on Nasdaq.</p>
<p>VSAC noted that the deficiencies related to the Market Value Requirement and the Total Holders Requirement are common for SPACs at the Company's current stage of completing a planned transaction. In its Compliance Plan submitted to Staff, VSAC has noted that the recently announced business combination with Mediforum Co., Ltd. ("<strong>Mediforum</strong>") will automatically resolve these deficiencies. The Company also noted that, if necessary, it can also consider implementing alternative solutions to the deficiencies to regain compliance with (a) the Market Value Requirement, by converting its Series B shares into Series A shares coupled with moving the company's listing to the Nasdaq Capital Market and (b) the Total Holders Requirement, by working with outside agencies to increase the number of Total Holders to above the minimum requirement.</p>
<p>On, February 7, 2024, the Company filed the outstanding 10-Q and regained compliance with Listing Rule 5250(c)(1).</p>
<p>On April 4, 2024, the Company met with the Nasdaq Hearings Panel ("Panel") and the Company management addressed Staff's concerns regarding timing issues in the business combination and presented a viable, concrete plan to regain compliance within the Panel's discretionary period while continuing to pursue a business combination.</p>
<p>On April 17, 2024, the Panel granted the request of VSAC to continue its listing on The Nasdaq Stock Market subject to the condition that on or before July 15, 2024, the Company will transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market and comply with all the applicable listing requirements of the Nasdaq Capital Market.&nbsp; The Company must provide prompt notification of any significant events that occur during this period that may affect the Company's compliance with the Nasdaq requirements, and the Nasdaq Hearing Panel reserves the right to reconsider the extension based on any event, condition or circumstance that exists or develops that would, in the opinion of the panel, make continued listing of the Company's securities on Nasdaq inadvisable or unwarranted.&nbsp; The Company intends to vigorously pursue its plan to return to compliance with the Nasdaq listing criteria on or prior to July 15, 2024.</p>
<p>The press release shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in the filing.</p>


VSAC

On April 17, 2024, The Panel Granted The Request Of VSAC To Continue Its Listing On The Nasdaq Stock Market Subject To The Condition That On Or Before July 15, 2024, The Co Will Transfer Its Listing From The Nasdaq Global Market To The Nasdaq Capital Market And Comply With All The Applicable Listing Requirements Of The Nasdaq Capital Market

<p>Financial giants have made a conspicuous bullish move on Medical Properties Trust. Our analysis of options history for Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $380,398, and 4 were calls, valued at $342,493.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $1.0 to $5.0 for Medical Properties Trust over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Medical Properties Trust's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Medical Properties Trust's substantial trades, within a strike price spectrum from $1.0 to $5.0 over the preceding 30 days.</p>
<h3>Medical Properties Trust Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553351_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.22</td>
<td>$0.21</td>
<td>$0.22</td>
<td>$4.00</td>
<td>$197.4K</td>
<td>49.8K</td>
<td>649</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$0.59</td>
<td>$0.54</td>
<td>$0.54</td>
<td>$5.00</td>
<td>$132.1K</td>
<td>14.4K</td>
<td>2.7K</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$2.06</td>
<td>$1.5</td>
<td>$1.81</td>
<td>$3.00</td>
<td>$123.6K</td>
<td>366</td>
<td>17</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$0.38</td>
<td>$0.35</td>
<td>$0.35</td>
<td>$5.00</td>
<td>$70.2K</td>
<td>9.7K</td>
<td>4.8K</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$0.46</td>
<td>$0.36</td>
<td>$0.41</td>
<td>$5.00</td>
<td>$59.7K</td>
<td>48.2K</td>
<td>1.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Medical Properties Trust</h3>
<p>Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.</p>
<h3>Medical Properties Trust's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 13,323,502, the MPW's price is down by -7.23%, now at $4.49. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 14 days.</li>
</ul>
<h3>Expert Opinions on Medical Properties Trust</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $4.833333333333333.</p>
<ul>
<li>An analyst from Colliers Securities persists with their Neutral rating on Medical Properties Trust, maintaining a target price of $5. </li>
<li>An analyst from Truist Securities persists with their Hold rating on Medical Properties Trust, maintaining a target price of $4. </li>
<li>Showing optimism, an analyst from Deutsche Bank upgrades its rating to Hold with a revised price target of $5. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Medical Properties Trust, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Medical Properties Trust's Options Frenzy: What You Need to Know

<p><strong>Stacks's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/stx/usd">STX</a>) price has increased 3.92% over the past 24 hours to <strong>$2.5</strong>, which is in the opposite direction of its trend over the past week, where it has experienced a 4.0% loss, moving from $2.62 to its current price.  As it stands right now, <strong>the coin's all-time high is $3.86</strong>. </p>
<p>The chart below compares the price movement and volatility for Stacks over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553346_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has decreased 35.0% over the past week, while the overall circulating supply of the coin has increased 3.88% to over 1.45 billion. This puts its current circulating supply at an estimated 79.95% of its max supply, which is 1.82 billion. The current market cap ranking for STX is #29 at $3.63 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553346_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$STX

Cryptocurrency Stacks's Price Increased More Than 3% Within 24 hours

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>U.S. Bancorp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with USB, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for U.S. Bancorp.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 46%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $118,483, and 11 are calls, for a total amount of $384,666.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $50.0 for U.S. Bancorp over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for U.S. Bancorp's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of U.S. Bancorp's whale activity within a strike price range from $35.0 to $50.0 in the last 30 days. </p>
<h3>U.S. Bancorp Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553345_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$7.25</td>
<td>$7.25</td>
<td>$35.00</td>
<td>$97.8K</td>
<td>1.9K</td>
<td>136</td>
</tr>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.76</td>
<td>$2.72</td>
<td>$2.76</td>
<td>$42.50</td>
<td>$34.7K</td>
<td>159</td>
<td>705</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$1.92</td>
<td>$1.89</td>
<td>$1.92</td>
<td>$37.50</td>
<td>$34.1K</td>
<td>569</td>
<td>712</td>
</tr>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.8</td>
<td>$2.78</td>
<td>$2.78</td>
<td>$42.50</td>
<td>$32.2K</td>
<td>159</td>
<td>1.0K</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$1.89</td>
<td>$1.88</td>
<td>$1.88</td>
<td>$37.50</td>
<td>$31.2K</td>
<td>569</td>
<td>400</td>
</tr>
</tbody>
</table>
</p>
<h3>About U.S. Bancorp</h3>
<p>As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in roughly 26 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.</p>
<p>After a thorough review of the options trading surrounding U.S. Bancorp, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>U.S. Bancorp's Current Market Status</h3>
<ul>
<li>Trading volume stands at 7,094,270, with USB's price up by 1.48%, positioned at $40.02.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 89 days.</li>
</ul>
<h3>Expert Opinions on U.S. Bancorp</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $49.6.</p>
<ul>
<li>Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on U.S. Bancorp with a target price of $43. </li>
<li>An analyst from Barclays persists with their Overweight rating on U.S. Bancorp, maintaining a target price of $52. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for U.S. Bancorp, targeting a price of $48. </li>
<li>Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Outperform rating for U.S. Bancorp, targeting a price of $52. </li>
<li>An analyst from HSBC has elevated its stance to Buy, setting a new price target at $53. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for U.S. Bancorp with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on USB Options

<p>Deep-pocketed investors have adopted a bearish approach towards Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CMG usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 62 extraordinary options activities for Chipotle Mexican Grill. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 30% leaning bullish and 69% bearish. Among these notable options, 29 are puts, totaling $2,542,575, and 33 are calls, amounting to $2,068,378.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1845.0 to $3700.0 for Chipotle Mexican Grill over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Chipotle Mexican Grill's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chipotle Mexican Grill's whale activity within a strike price range from $1845.0 to $3700.0 in the last 30 days. </p>
<h3>Chipotle Mexican Grill 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553340_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$279.0</td>
<td>$275.0</td>
<td>$275.0</td>
<td>$2950.00</td>
<td>$330.0K</td>
<td style="text-align: right;">128</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$285.8</td>
<td>$285.0</td>
<td>$285.0</td>
<td>$2950.00</td>
<td>$285.0K</td>
<td style="text-align: right;">128</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$203.0</td>
<td>$201.3</td>
<td>$203.0</td>
<td>$2800.00</td>
<td>$243.6K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$201.0</td>
<td>$200.2</td>
<td>$201.0</td>
<td>$2800.00</td>
<td>$241.2K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$205.0</td>
<td>$204.2</td>
<td>$205.0</td>
<td>$2800.00</td>
<td>$205.0K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">24</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chipotle Mexican Grill</h3>
<p>Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is predominately company-owned (it recently inked a development agreement with Alshaya Group in the Middle East), with a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although the firm maintains a small presence in Canada, the U.K., France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.</p>
<p>Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Chipotle Mexican Grill</h3>
<ul>
<li>Trading volume stands at 210,533, with CMG's price down by -1.99%, positioned at $2850.05.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 5 days.</li>
</ul>
<h3>What Analysts Are Saying About Chipotle Mexican Grill</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $3128.8.</p>
<ul>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Chipotle Mexican Grill, targeting a price of $2986. </li>
<li>An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Chipotle Mexican Grill, which currently sits at a price target of $3200. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Chipotle Mexican Grill, targeting a price of $3358. </li>
<li>An analyst from UBS has decided to maintain their Buy rating on Chipotle Mexican Grill, which currently sits at a price target of $3400. </li>
<li>Maintaining their stance, an analyst from Jefferies continues to hold a Hold rating for Chipotle Mexican Grill, targeting a price of $2700. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Chipotle Mexican Grill, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Chipotle Mexican Grill Options Trading: A Deep Dive into Market Sentiment

<p>Throughout the last three months, 4 analysts have evaluated Alpine Income Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $18.69, a high estimate of $19.00, and a low estimate of $18.00. Highlighting a 3.31% decrease, the current average has fallen from the previous average price target of $19.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553337_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Alpine Income Prop Trust by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.75</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>JonesTrading</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Gaurav Mehta</td>
<td>Alliance Global Partners</td>
<td>Announces</td>
<td>Buy</td>
<td>$19.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>JonesTrading</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Alpine Income Prop Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Alpine Income Prop Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Alpine Income Prop Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PINE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Alpine Income Prop Trust analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>About Alpine Income Prop Trust</h2>
<p>Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.</p>
<h3>A Deep Dive into Alpine Income Prop Trust's Financials</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Alpine Income Prop Trust faced challenges, resulting in a decline of approximately <strong>-4.62%</strong> in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Alpine Income Prop Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>3.03%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.13%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Alpine Income Prop Trust's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.06%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Alpine Income Prop Trust's debt-to-equity ratio is below the industry average at <strong>1.12</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PINE

Evaluating Alpine Income Prop Trust: Insights From 4 Financial Analysts

NeutriSci International

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for NeutriSci International Stock (OTC:NRXCF)

Thursday, November 21, 2019